Search results
Citi maintains buy on Axsome, price target steady at $125 By Investing.com
Investing.com· 5 days agoOn Wednesday, Citi reaffirmed its Buy rating on Axsome Therapeutics (NASDAQ:AXSM) with a consistent...
Axsome maintains Buy stock rating amid short report claims By Investing.com
Investing.com· 6 days agoOn Tuesday, Guggenheim reaffirmed its Buy rating on Axsome Therapeutics (NASDAQ:AXSM), despite a...
Free course shines light on sleep health | Newswise
Newswise· 3 days agoThe average person spends one-third of their life sleeping. In fact, said Ronald Chervin, M.D., a professor of neurology and director of the Sleep Disorders Centers at Michigan Medicine, “So ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stock Position Lowered by BVF Inc. IL
ETF DAILY NEWS· 4 days agoBVF Inc. IL cut its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 7.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned ...